About Akesis

At Akesis…

We believe people suffering from cancer and other intracranial diseases deserve the benefits of precise SRS treatment.

We believe clinicians should have the advanced tools they need to save lives and spare healthy tissue.

We believe healthcare providers should have affordable technology options that provide long-term value.

We’re Akesis. And we’re simplifying SRS.

2017

January

Private investors recognize the global opportunity.

2017

March

Veteran team of radiation oncology experts tapped to form new company.

2017

November

Akesis, Inc. is established. Akesis is a Greek god of healing.

2018

August

Grand Opening for new headquarters and manufacturing center.

2018

October

Akesis exhibits at ASTRO 2018.

2019

January

Contracts and supplier partnerships established.

2019

August

Manufacturing begins on our first products.

2019

September 4th

FDA clearance received for Akesis Galaxy.

2019

September 11-13th

Akesis exhibits at the ALATRO congress in Santiago, Chile.

2019

September 15-18th

Akesis exhibits at the ASTRO Annual Meeting in Chicago.

2019

October

Akesis exhibits at South African Association of Physicists in Medicine and Biology congress in Cape Town, South Africa.

2019

October

Akesis Receives California Food and Drug Branch (FDB) Device Manufacturing License.

2019

December

Akesis exhibits at the ASTRO meets Asia congress in Singapore.

2020

January 27-29th

Akesis exhibits at Arab Health 2020 in Dubai.

2020

February

Akesis Galaxy RTx receives FDA 510(k) clearance.

2021

March

Akesis Galaxy RTi receives FDA 510(k) clearance.